The Dot Corp Partners with ixlayer for Innovative Patient Solutions
The Dot Corp, a leader in high-quality printing, kitting, assembly, and fulfillment for healthcare and diagnostics, has teamed up with ixlayer. This collaboration aims to enhance direct-to-patient (DTP) healthcare solutions, particularly for biopharmaceutical companies. The partnership aims to strengthen the supply chain behind at-home diagnostics and patient onboarding, ultimately improving patient experiences.
ixlayer's Role in Direct-to-Patient Healthcare
ixlayer stands out as a pioneering platform that facilitates seamless healthcare services tailored for patients. This cloud-based platform integrates various services, connecting patients with laboratories, telehealth providers, prescriptions, and payment systems, all within a singular care pathway. Their offerings range from virtual onboarding and telehealth consultations to diverse lab testing options, including at-home kits and mobile phlebotomy.
Having successfully supported over a thousand national programs and guided more than four million patient journeys, ixlayer has developed initiatives such as at-home Complete Blood Count testing for monitoring and pre-treatment assessments. Additionally, recent surveys among pharmaceutical executives underscore a growing endorsement for direct-to-patient care models, indicating a shift towards more patient-centric approaches within the biopharma industry.
Ensuring compliance is critical for ixlayer. Their partner laboratories maintain certification through CLIA and CAP, ensuring quality and adherence to stringent healthcare regulations. Furthermore, ixlayer's infrastructure aligns with HITRUST, SOC2, and HIPAA standards, thereby safeguarding patient privacy and maintaining high standards across their vendor networks.
The Dot Corp's Contribution to Kitting and Fulfillment
The Dot Corp brings essential kitting infrastructure to support ixlayer's programs, ensuring operational consistency, quality assurance, and compliance with healthcare regulations. Their expertise encompasses:
- Designing and sourcing high-quality kits tailored specifically for at-home collection processes.
- Efficient fulfillment operations that can adapt to varying program volumes and quick deployment needs.
- Implementation of rigorous quality control measures and color matching across all production stages.
- Processes that comply with CLIA and CAP requirements, which also prioritize patient confidentiality.
- Adapting quickly to new program demands in specialty diagnostics and rare diseases, catering to substantial patient volumes.
- Strategic collaboration with biopharmaceutical partners keen on incorporating diagnostics, telehealth, and prescription services into their healthcare offerings.
This partnership is set to enhance the speed of launching DTP initiatives, fostering scalability while ensuring high-quality service delivery across the biopharma landscape.
A Unified Approach Towards Patient-Centric Care
Jeff Shattuck, CEO at The Dot Corp, emphasizes their shared vision: "Our aim is to minimize obstacles for biopharma programs reliant on timely testing and clear patient instructions. Collaborating with ixlayer enables us to boost the direct-to-patient experience on a national stage." This sentiment is echoed by Pouria Sanae, CEO and co-founder of ixlayer, who highlights how The Dot’s capabilities in supply chain management and fulfillment enhance their ability to serve a larger patient base efficiently.
The partnership between The Dot Corp and ixlayer is a notable step towards constructing a modern, reliable foundation for direct-to-patient diagnostics and treatment access, ensuring that patients receive the care they need with enhanced ease and efficiency.
About The Dot Corp
The Dot Corp stands as a premier solutions provider in the supply chain sector, focusing on healthcare, wellness kitting, eCommerce fulfillment, printing, and direct mail communications. Operating from four facilities in Southern California, the company boasts over 250 employees and 310,000 square feet of production and warehousing capabilities. Their comprehensive offerings encompass design, print production, kitting, fulfillment, and distribution, all while adhering to stringent FDA, BOP, GMP, ISO 13485, ISO 9001:2015 and HiTrust compliance standards.
About ixlayer
ixlayer is recognized for providing cloud-based platforms that streamline the healthcare experience. The name encapsulates their core strength, where the "i" symbolizes robust data and technology infrastructure, while the "x" stands for exceptional user experience. ixEngage, ixlayer's direct-to-patient platform tailored for biopharma, unites all ecosystem partners, fostering operational efficiency to accelerate the journey towards diagnosis and optimize health equity and outcomes for diverse patient populations. To date, ixlayer has facilitated over four million patient care journeys across more than 1,100 distinct programs, unraveling the complexities often associated with healthcare.
Frequently Asked Questions
What is the main objective of the partnership between The Dot Corp and ixlayer?
The primary aim is to enhance direct-to-patient healthcare solutions, improving supply chain efficiency for at-home diagnostics and patient onboarding.
What services does ixlayer provide?
ixlayer offers a cloud-based platform that integrates telehealth, lab testing, and patient onboarding into one care pathway.
How does The Dot Corp contribute to the partnership?
The Dot Corp provides essential kitting and fulfillment services, which enhance the quality and reliability of ixlayer's programs.
What compliance standards does ixlayer adhere to?
ixlayer ensures compliance with CLIA, CAP, HITRUST, SOC2, and HIPAA standards through its network of partner laboratories and service providers.
How many patient journeys has ixlayer facilitated?
ixlayer has successfully activated over four million patient journeys through its various healthcare programs.
